Back to Search
Start Over
Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts
- Source :
- Breast Cancer Research : BCR
- Publisher :
- Springer Nature
-
Abstract
- Introduction Microtubule associated proteins (MAPs) endogenously regulate microtubule stabilization and have been reported as prognostic and predictive markers for taxane response. The microtubule stabilizer, MAP-tau, has shown conflicting results. We quantitatively assessed MAP-tau expression in two independent breast cancer cohorts to determine prognostic and predictive value of this biomarker. Methods MAP-tau expression was evaluated in the retrospective Yale University breast cancer cohort (n = 651) using tissue microarrays and also in the TAX 307 cohort, a clinical trial randomized for TAC versus FAC chemotherapy (n = 140), using conventional whole tissue sections. Expression was measured using the AQUA method for quantitative immunofluorescence. Scores were correlated with clinicopathologic variables, survival, and response to therapy. Results Assessment of the Yale cohort using Cox univariate analysis indicated an improved overall survival (OS) in tumors with a positive correlation between high MAP-tau expression and overall survival (OS) (HR = 0.691, 95% CI = 0.489-0.974; P = 0.004). Kaplan Meier analysis showed 10-year survival for 65% of patients with high MAP-tau expression compared to 52% with low expression (P = .006). In TAX 307, high expression was associated with significantly longer median time to tumor progression (TTP) regardless of treatment arm (33.0 versus 23.4 months, P = 0.010) with mean TTP of 31.2 months. Response rates did not differ by MAP-tau expression (P = 0.518) or by treatment arm (P = 0.584). Conclusions Quantitative measurement of MAP-tau expression has prognostic value in both cohorts, with high expression associated with longer TTP and OS. Differences by treatment arm or response rate in low versus high MAP-tau groups were not observed, indicating that MAP-tau is not associated with response to taxanes and is not a useful predictive marker for taxane-based chemotherapy.
- Subjects :
- Adult
Oncology
Cytoplasm
medicine.medical_specialty
Pathology
Breast Neoplasms
tau Proteins
Docetaxel
Kaplan-Meier Estimate
Cohort Studies
Breast cancer
Predictive Value of Tests
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Humans
Medicine
predictive
Cyclophosphamide
Survival rate
Aged
Randomized Controlled Trials as Topic
Retrospective Studies
Aged, 80 and over
Medicine(all)
Univariate analysis
Predictive marker
Taxane
quantitative analysis
business.industry
Epithelial Cells
Retrospective cohort study
Middle Aged
Prognosis
medicine.disease
taxanes
Survival Rate
Doxorubicin
Predictive value of tests
immunohistochemistry
Biomarker (medicine)
Female
Taxoids
metastatic breast cancer
Fluorouracil
business
microtubule associated protein- tau (MAP-tau)
prognostic
Research Article
Subjects
Details
- Language :
- English
- ISSN :
- 1465542X
- Volume :
- 13
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Breast Cancer Research
- Accession number :
- edsair.doi.dedup.....0d6bcc4262f508480069b4a32ef2b1b1
- Full Text :
- https://doi.org/10.1186/bcr2937